MDR 5.13% 41.0¢ medadvisor limited

Ann: Appendix 4D and Half Yearly Report, page-5

  1. 316 Posts.
    lightbulb Created with Sketch. 66
    you are spot on! Their business model does not work. They add vary little value to their pharmacy relationships cause they can't get consumers to use their app. It's pathetic and that is why the SP is going no where IMO, yet the board continues to issue management performance options - when there is no performance! Joke.
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.